Photo by nci from unsplash
We read with interest the recent report by Mathian et al 1 regarding the clinical course of COVID-19 infection in 17 patients with systemic lupus erythematosus (SLE) under long-term hydroxychloroquine… Click to show full abstract
We read with interest the recent report by Mathian et al 1 regarding the clinical course of COVID-19 infection in 17 patients with systemic lupus erythematosus (SLE) under long-term hydroxychloroquine treatment. We report supportive findings in five patients with SLE, contextualised in a larger cohort of patients with rheumatological conditions, from an academic, tertiary-care population. Between 1 March and 20 April 2020, 31 patients followed at University of Michigan rheumatology clinics were diagnosed with COVID-19 (see online supplementary table 1). Five (16%) of these patients had SLE, four of whom were taking hydroxychloroquine with a median (range) duration of …
Journal Title: Annals of the Rheumatic Diseases
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!